May 8, 2024 LOS ALTOS, Calif. — SightGlass Vision presented four studies at the Association for Research in Vision and Ophthalmology (ARVO)...
February 14, 2024 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses have received Breakthrough Device designation from the...
October 16, 2023 NEW ORLEANS, La. — At the American Academy of Optometry’s 2023 Annual Meeting, SightGlass Vision shared three studies that...
September 20, 2023 LOS ALTOS, Calif. — SightGlass Vision’s Diffusion Optics Technology (DOT) spectacle lenses are the subject of a recently released...
September 5, 2023 CHANGSHA, China — At the Congress of the Chinese Ophthalmological Society (CCOS) in Changsha, SightGlass Vision shared the four-year results...
October 25, 2022 LOS ALTOS, Calif. — New findings from SightGlass Vision’s three-year CYPRESS clinical trial have highlighted the efficacy of the...
June 23, 2022 PALO ALTO, Calif. — In analyzing two-year data from SightGlass Vision’s CYPRESS clinical trial, experts have learned that the...
March 24, 2022 PALO ALTO, Calif. — SightGlass Vision announced the appointment of three new leadership positions to its executive team. Andrew...